u/rania_diallo

the dual agonism hits different and that is why people describe it differently

Cosigning. The GIP contribution is real and the side effects are not simply scaled versions.

regulatory claims need a citation to the actual rule, not interpretation

Disagree on that part. 96.2% and 96.8% on the same vial is normal.

Dead space in the needle hub holds a small but non-trivial volume. On low-volume draws that can be several units.

What colour is the pen? Wegovy and Ozempic use different formulations.

Not to be pedantic but plateau and food noise are being used interchangeably and they are not interchangeable in real life.

The dual agonism story is real. The appetite is physically different from semaglutide alone.

Tried both. Sema worked, tirz worked better for me, but my early fullness profile was worse on tirz.

Week 13 on Mounjaro and 24kg down. The appetite reduction feels different from sema in ways I do not have words for yet.

Flair changed to match the content.

Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.

the food-noise thing stops around week 91 for most people

Are we talking 503A or 503B?

the quiet is real. the food noise just stops.

No. This is the kind of confident post that gets copied into a screenshot and repeated for years. Where is the evidence.

name your province, coverage is provincial

the early fullness from tirz is different, not necessarily worse

Water content matters more than people think. If a vial is carrying residual moisture, your "10mg" is not 10mg of peptide.

stalled on sema, tried tirz, and the curves were actually different shapes

a dispute resolves, edit the post and say so

Did they tell you their API source or dodge the question?